CVR number 37377066
Industry 70.2200 Business and other management consultancy activities

MedAssist ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  1.3% 1.3% 1.1% 1.3% 1.6%  
Credit score (0-100)  82 80 83 79 74  
Credit rating  A A A A A  
Credit limit (kDKK)  232.4 253.4 655.6 319.2 80.6  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  28,154 33,346 28,000 37,694 47,451  
EBITDA  4,022 6,379 5,090 8,343 11,802  
EBIT  3,834 6,125 4,827 8,037 11,356  
Pre-tax profit (PTP)  3,812.1 6,060.4 4,758.7 8,035.3 11,481.1  
Net earnings  2,971.0 4,727.4 3,711.8 6,216.4 8,954.6  
Pre-tax profit without non-rec. items  3,812 6,060 4,759 8,035 11,481  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  714 525 346 707 868  
Shareholders equity total  3,971 6,098 5,610 8,527 11,881  
Interest-bearing liabilities  0.0 23.1 22.1 162 83.2  
Balance sheet total (assets)  9,528 11,801 8,975 13,412 17,858  
Net Debt  -7,711 -9,602 -5,803 -9,579 -14,022  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  28,154 33,346 28,000 37,694 47,451  
Gross profit growth  44.8% 18.4% -16.0% 34.6% 25.9%  
Employees  26 29 24 27 34  
Employee growth %  52.9% 11.5% -17.2% 12.5% 25.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  9,528 11,801 8,975 13,412 17,858  
Balance sheet change%  176.8% 23.9% -24.0% 49.4% 33.2%  
Added value  4,022.5 6,378.9 5,089.6 8,300.0 11,801.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  105 -444 -442 55 -284  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  13.6% 18.4% 17.2% 21.3% 23.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  59.1% 57.5% 46.5% 72.1% 73.6%  
ROI %  145.3% 121.2% 82.1% 112.0% 110.4%  
ROE %  113.0% 93.9% 63.4% 87.9% 87.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  41.7% 51.7% 62.5% 63.6% 66.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -191.7% -150.5% -114.0% -114.8% -118.8%  
Gearing %  0.0% 0.4% 0.4% 1.9% 0.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 582.0% 301.5% 34.7% 18.3%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.5 1.9 2.5 3.9 4.9  
Current Ratio  1.5 1.9 2.5 4.0 4.9  
Cash and cash equivalent  7,711.3 9,625.1 5,825.5 9,740.3 14,105.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  2,990.1 5,303.9 4,991.2 9,196.8 13,094.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  155 220 212 307 347  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  155 220 212 309 347  
EBIT / employee  147 211 201 298 334  
Net earnings / employee  114 163 155 230 263